Open access · OA
via Europe PMC
Glycated hemoglobin (A1c) values and antidiabetic treatment deprescription in hospitalized nonagenarians with type 2 diabetes.
Morros-González E, Triviño-Beleño PA, Villamizar ES, Torres-Arias N, Marriaga-Ángel Á.
Frontiers in public health · 2026
Abstract
<h4>Introduction</h4>Type 2 diabetes mellitus is highly prevalent among older adults and associated with frailty, functional decline, and increased healthcare utilization. Evidence on metabolic control and therapeutic management in hospitalized nonagenarians remains scarce, particularly in low- and middle-income country settings. This study aimed to describe glycated hemoglobin (A1c) and antidiabetic treatment modifications during hospitalization in nonagenarians with type 2 diabetes, within the context of their clinical, functional, and geriatric characteristics.<h4>Materials and methods</h4>A descriptive, retrospective, cross-sectional study based on an institutional registry from the geriatric service of a high-complexity hospital in Bogotá, Colombia (2022-2024). Individuals aged ≥90 years with a history of type 2 diabetes mellitus documented at admission were included. A1c values, antidiabetic treatment at admission and discharge and geriatric characteristics were analyzed descriptively.<h4>Results</h4>Among 195 nonagenarians, mean age was 92 ± 2 years and 60.00% were women. Infectious conditions were the most frequent admission diagnoses. Median Barthel Index score was 55 points (IQR 20-80); frailty (CFS ≥ 5) was identified in 89.20%, delirium at admission in 39.49%, and major neurocognitive disorder in 16.41%. Of patients with formal nutritional assessment (<i>n</i> = 103), 52.43% had moderate-to-severe malnutrition. Polypharmacy was present in 80.00%, with a median of 7 medications (IQR 5-9). Despite this clinical burden, 74.38% of patients with available A1c (<i>n</i> = 121) had values <7.5%, suggesting potential overtreatment. At discharge, the proportion without antidiabetic pharmacological treatment increased from 26.15 to 46.20%, with reductions in metformin, DPP-4 inhibitors, and insulin prescriptions, and an increase in SGLT-2 inhibitor use.<h4>Conclusion</h4>The coexistence of low A1c values and high burden of frailty, malnutrition, and polypharmacy reveals a critical discordance between therapeutic intensity and clinical status. These findings highlight a gap in ambulatory therapeutic review and support the need for individualized goals, deprescription protocols, and interdisciplinary care models bridging hospital, community, and domiciliary settings, a public health priority for aging populations in Latin America.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fpubh.2026.1900588
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
E, M., PA, T., ES, V., N, T., & Á., M. (2026). Glycated hemoglobin (A1c) values and antidiabetic treatment deprescription in hospitalized nonagenarians with type 2 diabetes. <em>Frontiers in public health</em>. https://doi.org/10.3389/fpubh.2026.1900588
Vancouver
E M, PA T, ES V, N T, Á. M. Glycated hemoglobin (A1c) values and antidiabetic treatment deprescription in hospitalized nonagenarians with type 2 diabetes. Frontiers in public health. 2026. doi:10.3389/fpubh.2026.1900588.
BibTeX
@article{morrosgonzlez2026Glycat,
title = {Glycated hemoglobin (A1c) values and antidiabetic treatment deprescription in hospitalized nonagenarians with type 2 diabetes.},
author = {Morros-González E and Triviño-Beleño PA and Villamizar ES and Torres-Arias N and Marriaga-Ángel Á.},
journal = {Frontiers in public health},
year = {2026},
doi = {10.3389/fpubh.2026.1900588},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diskapi Yildirim Beyazit Education and Research Hospital 2020
Open access · US-GOV
Correlation of Clinical Frailty Scale and Modified Frailty Index in Intensive Care Patients
Успехи геронтологии 2025
Open access · OA
СТРУКТУРА САХАРОСНИЖАЮЩЕЙ ТЕРАПИИ КОМОРБИДНОГО ПОЖИЛОГО ПАЦИЕНТА С САХАРНЫМ ДИАБЕТОМ 2-ГО ТИПА ПО ДАННЫМ АМБУЛАТОРНОГО СПЕЦИАЛИЗИРОВАННОГО РЕГИСТРА
The Journals of Gerontology Series A 2021
Preprint · OA
Eight-Year Changes in Multimorbidity and Frailty in Adults With Type 2 Diabetes Mellitus: Associations With Cognitive and Physical Function and Mortality
Assiut University 2026
Open access · US-GOV
Frailty Syndrome and Its Associated Factors Among Elderly Patients Attending Assiut University Hospitals
Hospital Universitari Vall d'Hebron Research Institute 2025
Open access · US-GOV
ASSESSMENT of FRAILTY AS a PROGNOSTIC FACTOR for MORTALITY, DISABILITY, and QUALITY of LIFE AFTER ICU ADMISSION
Zhejiang Hospital 2023
Open access · US-GOV